Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Vaccines as a remedy for antimicrobial resistant bacterial infections

Publicaciones

SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly

Autores: Onnis, A. et al.
Publicado en: Journal of Experimental Medicine 220, e20220906, Edición e20220906, 2022, ISSN 0022-1007
Editor: Rockefeller University Press
DOI: 10.1084/jem.20220906

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

Autores: Torres Jonathan, L. et al.
Publicado en: Proceedings of the National Academy of Sciences 119, 2022, ISSN 0027-8424
Editor: National Academy of Sciences
DOI: 10.1073/pnas.2120976119

Antimicrobial Resistance: A Tale of Nasty Enemies and Powerful Weapons

Autores: Fabiola Vacca, Dario Cardamone, Marco Troisi, Claudia Sala, Rino Rappuoli
Publicado en: Frontiers for Young Minds, Edición 8, 2020, ISSN 2296-6846
Editor: Frontiers Media S.A.
DOI: 10.3389/frym.2020.554493

Antibodies, epicenter of SARS-CoV-2 immunology

Autores: Simone Pecetta, Mariagrazia Pizza, Claudia Sala, Emanuele Andreano, Piero Pileri, Marco Troisi, Elisa Pantano, Noemi Manganaro, Rino Rappuoli
Publicado en: Cell Death & Differentiation, Edición 28/2, 2021, Página(s) 821-824, ISSN 1350-9047
Editor: Nature Publishing Group
DOI: 10.1038/s41418-020-00711-w

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants

Autores: Andreano, E. et al.
Publicado en: Nature 600, pages530–535 (2021), Edición Nature 600, pages530–535, 2021, ISSN 0028-0836
Editor: Nature Publishing Group
DOI: 10.1038/s41586-021-04117-7

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Autores: Emanuele Andreano, Emanuele Nicastri, Ida Paciello, Piero Pileri, Noemi Manganaro, Giulia Piccini, Alessandro Manenti, Elisa Pantano, Anna Kabanova, Marco Troisi, Fabiola Vacca, Dario Cardamone, Concetta De Santi, Jonathan L. Torres, Gabriel Ozorowski, Linda Benincasa, Hyesun Jang, Cecilia Di Genova, Lorenzo Depau, Jlenia Brunetti, Chiara Agrati, Maria Rosaria Capobianchi, Concetta Castilletti, Ar
Publicado en: Cell, Edición 184/7, 2021, Página(s) 1821-1835.e16, ISSN 0092-8674
Editor: Cell Press
DOI: 10.1016/j.cell.2021.02.035

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies

Autores: Andreano, E. & Rappuoli, R.
Publicado en: Nature Medicine 27, 759-761, Edición Nature Medicine 27, 759-761, 2021, ISSN 1078-8956
Editor: Nature Publishing Group
DOI: 10.1038/s41591-021-01347-0

A new dawn for monoclonal antibodies against antimicrobial resistant bacteria

Autores: Troisi, M. et al.
Publicado en: Frontiers in Microbiology 13, Edición Frontiers in Microbiology 13, 2022, ISSN 1664-302X
Editor: Frontiers Media
DOI: 10.3389/fmicb.2022.1080059

Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana

Autores: Frigerio, R. et al.
Publicado en: Frontiers in Plant Science 13, Edición Frontiers in Plant Science 13, 2022, ISSN 1664-462X
Editor: Frontiers Media S. A.
DOI: 10.3389/fpls.2022.956741

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response

Autores: Andreano, E. et al.
Publicado en: Nature Communications, Edición 14, Article number: 53 (2023), 2023, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-022-35781-6

High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae

Autores: S. Stazzoni et al.
Publicado en: Front. Microbiol. Sec. Antimicrobials, Resistance and Chemotherapy, Edición Front. Microbiol., Sec. Antimicrobials, Resistance and Chemotherapy Volume 14 – 2023, 2023, ISSN 1664-302X
Editor: Frontiers Media
DOI: 10.3389/fmicb.2023.1243427

Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection

Autores: Lanini, S. et al.
Publicado en: Nature Communications 13, 2263, 2022, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-022-29909-x

Vaccines as remedy for antimicrobial resistance and emerging infections

Autores: Marco Troisi, Emanuele Andreano, Claudia Sala, Anna Kabanova, Rino Rappuoli
Publicado en: Current Opinion in Immunology, Edición 65, 2020, Página(s) 102-106, ISSN 0952-7915
Editor: Elsevier BV
DOI: 10.1016/j.coi.2020.09.003

Immunodominant antibody germlines in COVID-19

Autores: Andreano, E. & Rappuoli, R.
Publicado en: Journal of Experimental Medicine 218, Edición Journal of Experimental Medicine 218, 2021, ISSN 0022-1007
Editor: Rockefeller University Press
DOI: 10.1084/jem.20210281

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections

Autores: Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, Claudia Sala, Rino Rappuoli
Publicado en: Biomedicines. 2022 Aug 2;10(8):1861, Edición Biomedicines. 2022 Aug 2;10(8):1861, 2022, ISSN 0753-3322
Editor: Elsevier Masson
DOI: 10.3390/biomedicines10081861

Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions

Autores: Fabiola Vacca, Claudia Sala, Rino Rappuoli
Publicado en: Biomedicines 30;10(9):2126, Edición Biomedicines 30;10(9):2126, 2022, ISSN 0753-3322
Editor: Elsevier Masson
DOI: 10.3390/biomedicines10092126

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

Autores: Emanuele Andreano, Giulia Piccini, Danilo Licastro, Lorenzo Casalino, Nicole V. Johnson, Ida Paciello, Simeone Dal Monego, Elisa Pantano, Noemi Manganaro, Alessandro Manenti, Rachele Manna, Elisa Casa, Inesa Hyseni, Linda Benincasa, Emanuele Montomoli, Rommie E. Amaro, Jason S. McLellan, Rino Rappuoli
Publicado en: Proceedings of the National Academy of Sciences, Edición 118/36, 2021, Página(s) e2103154118, ISSN 0027-8424
Editor: National Academy of Sciences
DOI: 10.1073/pnas.2103154118

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees

Autores: Andreano, E. et al.
Publicado en: Nature Communications 13, 3375, Edición Nature Communications 13, 3375, 2022, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-022-31115-8

High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies

Autores: Paciello, I., Maccari, G., Pantano, E., Andreano & Rappuoli, R
Publicado en: Proceedings of the National Academy of Sciences 121, e2314730121 (2024), Edición 121, e2314730121 (2024), 2024, ISSN 0027-8424
Editor: National Academy of Sciences
DOI: 10.1073/pnas.2314730121

mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5

Autores: Emanuele Andreano, Ida Paciello, Giulio Pierleoni, Giuseppe Maccari, Giada Antonelli, Valentina Abbiento, Piero Pileri, Linda Benincasa, Ginevra Giglioli, Giulia Piccini, Concetta De Santi, Claudia Sala, Duccio Medini, Emanuele Montomoli, Piet Maes & Rino Rappuoli
Publicado en: Nature Communication, Edición (2023) 14:1734, 2023, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-023-37422-y

Human monoclonal antibodies reveal subdominant gonococcal and meningococcal cross-protective antigens

Autores: Troisi, M., et al.
Publicado en: COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv, Edición 2023.2012.2007.570438, 2023, ISSN 2692-8205
Editor: bioRxiv
DOI: 10.1101/2023.12.07.570438

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles